After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Krystal Biotech Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Krystal Biotech Inc is $5.73B. A total of 0.62 million shares were traded on the day, compared to an average of 348.09K shares.
In the most recent transaction, Krishnan Suma sold 13,435 shares of KRYS for 150.30 per share on Jul 14 ’25. After the transaction, the President, R&D now owns 1,443,276 company shares. In a previous transaction on Jul 14 ’25, Krishnan Suma sold 13,400 shares at 150.30 per share. KRYS shares that President, R&D owns now total 1,512,529.
Among the insiders who sold shares, Krishnan Suma disposed of 3,084 shares on Jul 15 ’25 at a per-share price of $151.01. This resulted in the President, R&D holding 1,509,445 shares of KRYS after the transaction. In another insider transaction, Krishnan Suma sold 3,036 shares at $150.98 per share on Jul 15 ’25. Company shares held by the President, R&D now total 1,440,240.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, KRYS has a high of $207.84 and a low of $122.80.
As of this writing, KRYS has an earnings estimate of $1.25 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of $1.67 per share and a lower estimate of $1.08. The company reported an EPS of $1.53 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. KRYS’s latest balance sheet shows that the firm has $438.10M in Cash & Short Term Investments as of fiscal 2021. There were $8.02M in debt and $25.74M in liabilities at the time. Its Book Value Per Share was $35.97, while its Total Shareholder’s Equity was $593.58M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KRYS is Buy with a score of 4.67.
